Showing results (91-100 of 157) with videos related to
Sort By:
Pageof 16
Chemmedchem|April 15, 2021
Development and in vitro Profiling of Dual FXR/LTA4H ModulatorsSimone Schierle, Steffen Brunst, Moritz Helmstädter, et al.Chemical Science|March 20, 2020
Optical control of the nuclear bile acid receptor FXR with a photohormoneJohannes Morstein, Julie B Trads, Konstantin Hinnah, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 30, 2022
Nurr1 Modulation Mediates Neuroprotective Effects of StatinsSabine Willems, Julian A Marschner, Whitney Kilu, et al.ACS Medicinal Chemistry Letters|September 19, 2019
A Novel Biphenyl-based Chemotype of Retinoid X Receptor Ligands Enables Subtype and Heterodimer PreferencesJulius Pollinger, Simone Schierle, Leonie Gellrich, et al.Bioconjugate Chemistry|May 25, 2026
Enhanced Intramuscular mRNA Activity of Peptide-Lipid Nanoparticles with Hydrophobized Head GroupsEric Weidinger, Tobias Burghardt, Lennart Obeser, et al.Journal of Medicinal Chemistry|February 7, 2025
A Nurr1 Agonist Derived from the Natural Ligand DHI Induces Neuroprotective Gene ExpressionMarkus Egner, Romy Busch, Úrsula López-García, et al.Communications Chemistry|July 1, 2024
Development of Nurr1 agonists from amodiaquine by scaffold hopping and fragment growingMinh Sai, Emily C Hank, Hin-Man Tai, et al.Bioorganic Chemistry|September 26, 2022
Fragment-based discovery of orphan nuclear receptor Nur77/NGFI-B ligandsSilvia Arifi, Daniel Zaienne, Jan Heering, et al.Food & Function|December 23, 2022
State-of-the-art methodological investigation of carotenoid activity and metabolism - from organic synthesis <i>via</i> metabolism to biological activity - exemplified by a novel retinoid signalling pathwayTorsten Bohn, Angel R de Lera, Jean-Francois Landrier, et al.Journal of Medicinal Chemistry|July 24, 2025
Development of an RXR Agonist Scaffold with Pronounced Homodimer PreferenceFelix Nawa, Arthur Kardanov, Till Kasch, et al.Pageof 16